Pain Neuroscience Education and Graded Exposure to Movement in Breast Cancer Survivors
Online Pain Neuroscience Education and Graded Exposure to Movement in Breast Cancer Survivors: Protocol of a Randomised Controlled Trial.
1 other identifier
interventional
40
1 country
1
Brief Summary
Introduction: Pain stands out among the sequelae that affect the quality of life of breast cancer survivors. Pain neuroscience education and graded exposure to movement are therapeutic approaches that have been shown to be effective in the management of chronic pain in other populations. However, there are no previous studies that combine them in this population. Objective: To evaluate the effectiveness of an online physiotherapy focused-person program which combines pain neuroscience education and graded exposure to movement, to improve the quality of life of breast cancer survivors. Methodology: The design of the study is a randomised controlled clinical trial and the sample will be 40 breast cancer survivors with pain in the last 6 months. A random method will be used to assign participants into two groups (experimental and control). The evaluator and statistician will be blinded to participant allocation while the experimental group will receive the therapeutic program which combines pain neuroscience education and graded exposure to movement-based intervention throughout therapeutic yoga; the control will be a passive group. There will be four points of assessment: the main outcome assessed will be quality of life measured by the Functional Assessment of Cancer Therapy - Breast (FACT-B+4) and the secondary outcomes are variables related to pain experience (catastrophising, self-efficacy, kinesiophobia and fear-avoidance behaviours). All will be assessed using validated methods. SPSS program will be used for the data analysis. A mixed-model analyses of variance ANOVA (2x4) will be used to study the effects of the treatment on the dependent variables. An intention-to-treat analysis will be performed. All statistical tests will be performed considering a confidence interval of 95%. Trial record: NCT04965909.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 26, 2021
CompletedFirst Posted
Study publicly available on registry
July 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedDecember 28, 2023
December 1, 2023
3.7 years
June 26, 2021
December 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from quality of life
Quality of life measured by the Functional Assessment of Cancer Therapy - Breast (FACT-B+4). The FACT-B+4 is a 41-item instrument designed to measure six domains of QOL in breast cancer patients: Physical, social, emotional and functional well-being, and breast-cancer (BCS) and lymphedema (ARM) subscales. The score obtained ranges from 0-148 points. The ARM subscale was not included in the total score. A higher score translates into a better quality of life.
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Secondary Outcomes (5)
Change from pain intensity
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Change from catastrophism level
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Change from self-efficacy level
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Change from Kinesiophobia
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Change from Fear Avoidance Beliefs
Four evaluations will be made, before the intervention (T0, at the baseline), at the end of the application of PNE module (T1, 1 month), at the end of the GEM intervention (T2, 3 month) and at 3 months of follow-up (T3).
Study Arms (2)
Educational and therapeutic exercise program
EXPERIMENTALParticipants will receive a 3-month online physiotherapy program comprised of 'pain neuroscience education' (month 1) and 'gradual exposure to movement' (month 2 and 3). They will receive an informative booklet online.
Passive control group (usual care)
NO INTERVENTIONParticipants will receive the 'usual care'. They will receive an informative booklet online and the possibility of receiving the therapeutic program, once the study is completed.
Interventions
Online group therapeutic program (small groups), applied for 3 months.
Eligibility Criteria
You may qualify if:
- Woman aged between 18 - 65 years.
- Diagnosis of stage 0 - III breast cancer.
- Primary treatment (surgery, radiotherapy and chemotherapy) completed at least 3 months ago may still be receiving hormonal therapy.
- Pain related to primary treatment in the last 6 months.
- Access to Internet and an electronic device that allows the use of the applications used in this study and skills for their use or assistance from a close person who has them.
- Ability to communicate fluently verbally and in writing in the language of the research team (Spanish).
- Approval of participation in the study by the coordinator of the health team that assisted her during the course of cancer and its treatment.
You may not qualify if:
- Another previous type of cancer or breast cancer recurrence in a period of less than 1 year.
- Medical diagnosis of a neurological, autoimmune or cardiovascular disease.
- Some type of pathology that is associated with a contraindication to physical exercise.
- Diagnosis of serious psychiatric or neurologic disorders that do not allow the participant to follow orders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Sevilla, departamento de Fisioterapia
Seville, 41009, Spain
Related Publications (6)
Watson JA, Ryan CG, Cooper L, Ellington D, Whittle R, Lavender M, Dixon J, Atkinson G, Cooper K, Martin DJ. Pain Neuroscience Education for Adults With Chronic Musculoskeletal Pain: A Mixed-Methods Systematic Review and Meta-Analysis. J Pain. 2019 Oct;20(10):1140.e1-1140.e22. doi: 10.1016/j.jpain.2019.02.011. Epub 2019 Mar 1.
PMID: 30831273BACKGROUNDDe Groef A, Penen F, Dams L, Van der Gucht E, Nijs J, Meeus M. Best-Evidence Rehabilitation for Chronic Pain Part 2: Pain during and after Cancer Treatment. J Clin Med. 2019 Jul 5;8(7):979. doi: 10.3390/jcm8070979.
PMID: 31284377BACKGROUNDCramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD010802. doi: 10.1002/14651858.CD010802.pub2.
PMID: 28045199BACKGROUNDGatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007 Jul;133(4):581-624. doi: 10.1037/0033-2909.133.4.581.
PMID: 17592957BACKGROUNDMartinez-Miranda P, Jimenez-Rejano JJ, Munoz-Fernandez MJ, Garcia-Munoz C, Casuso-Holgado MJ. Effectiveness of an interactive online group intervention based on pain neuroscience education and graded exposure to movement in breast cancer survivors with chronic pain: a randomised controlled trial. Support Care Cancer. 2024 Oct 7;32(10):705. doi: 10.1007/s00520-024-08887-4.
PMID: 39373766DERIVEDMartinez-Miranda P, Casuso-Holgado MJ, Garcia-Munoz C, Munoz-Fernandez MJ, Jimenez-Rejano JJ. Online pain neuroscience education and graded exposure to movement in breast cancer survivors: protocol of a randomized controlled trial. Front Med (Lausanne). 2024 Feb 28;11:1355964. doi: 10.3389/fmed.2024.1355964. eCollection 2024.
PMID: 38482528DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- double-blind (researcher and statistician)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoranda Programa del Doctorado Interuniversitario en CCSS
Study Record Dates
First Submitted
June 26, 2021
First Posted
July 16, 2021
Study Start
April 1, 2021
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
December 28, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share
The personal data of the participants will be treated in accordance with the Organic Law 3/2018, of December 5, on the Protection of Personal Data and guarantee of digital rights